The main objective is to evaluate the efficacy of Azéol Spray Nasal, taken two times a day,
versus placebo on nasal congestion in subject with common cold.
This study is designed as a multicentric, randomized, double-blind, placebo-controlled with
two-arm parallel groups clinical trial. 144 subjects presenting with early symptoms of common
cold will be recruited for this study, according to the defined inclusion and exclusion
criteria. The main objective is to evaluate the efficacy of Azéol Spray Nasal
(Bifidobacterium breve LA 708, extract of cypres Cupressus sempervirens L., extract of
Leguminosae Glycyrrhiza glabra L., glycerin and mannitol), taken two times a day, versus
placebo on nasal congestion in subject with common cold.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.